Tamarack Biotics
  • Home
  • About
  • Benefits and Applications
  • Products
  • News
  • Contact

Immunosenescence Clinical Trial Paper Published

Posted on  October 20, 2018
  · No Comments

An immunosenescence clinical trial using TruActive MPC 85 was published this week in Frontiers in Immunology. Read “Use of UV Treated Milk Powder to Increase Vaccine Efficacy in the Elderly”.

“We are very excited that such an esteemed publication chose to publish our groundbreaking study of immune response improvement from consuming the immune active proteins contained in our TruActive MPC 85 product,” said Bob Comstock, CEO of Tamarack Biotics.  “As you likely know, immune systems weaken as we age, and TruActive strengthens immune response in the elderly.  The scientific evidence leads us to believe TruActive will keep elderly people well.”

Categories : Uncategorized
← Next Post
Previous Post →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent Posts

  • Tamarack Biotics Featured on Dairy Dialog podcast
  • Immunosenescence Clinical Trial Paper Published
  • Tamarack Biotics Announces TruActive Clinical Trial
  • Science, Sweeteners, & Safe Raw Milk
  • TruActive MPC 85 elicits high antibody response in people over 60
Tamarack Biotics
Copyright © 2023 All Rights Reserved
Site built with Bet Hannon Business Websites
  Privacy Policy
Top